New Jersey VIOXX® Verdict

New Jersey Jury Awards $9 Million in Punitive Damages Against Maker of VIOXX®

(Atlantic City, N.J.) A jury in New Jersey Superior Court Judge Carol E.Higbee's court has awarded punitive damages against Merck & Co, manufacturer of VIOXX®. Jurors found that the drug maker intentionally withheld from the federal Food and Drug Administration damaging information about the VIOXX®. The arthritis drug has been linked to increased incidences of heart attacks and strokes.

Jurors awarded John McDarby, 76, of Park Ridge, N.J., $9 million in punitive damages. Previously, jurors had awarded McDarby $4.5 million in compensatory damages.

Mark Lanier argued on behalf of Mr. McDarby during the punitive phase. "We have crossed a threshold in these VIOXX® cases. Because of this jury, we know that Merck not only failed to warn consumers about the dangers of their drug, they actually built a wall of deception and lies," says Lanier. "Merck can no longer claim that they tried to do the right thing in marketing and developing VIOXX®"

At the conclusion of testimony jurors, in awarding $4.5 million to Mr. McDarby, found that the company failed to warn consumers about research data that showed VIOXX® users were twice as likely to suffer from heart attacks as compared to users of competing arthritis drugs. The jurors agreed that VIOXX® had contributed to causing Mr. McDarby's heart attack. He took the drug for four years. Jurors also awarded $135 to Thomas Cona, 60, of Cherry Hill, NJ, to cover the cost of his prescriptions. Jurors decided that VIOXX® did not contribute to Mr. Cona's heart attack.

This is the second plaintiff's verdict against Merck & Co. in connection with its controversial VIOXX® painkiller, which Merck withdrew from the market in September 2004.

Last August, a jury in Brazoria County, Texas, awarded a $253 million verdict against Merck. In that case, the jury ruled against Merck on each of three key questions: they found Merck failed to warn doctors about the danger posed by VIOXX®, that the drug was improperly designed, and that Merck's negligence caused the death of Robert Ernst, a physically fit triathlete.

If you or a loved one has suffered injuries as a result of his/her use of a pharmaceutical drug, please contact our office for a free evaluation.

PDF
Print
lanier-sugar-attorney.jpg

Law Firm News

Vioxx Settlement Update

Information for Vioxx clients awaiting information on claims package approval.


Duragesic Fentanyl Patch

Product recalls have been issued for fentanyl patches following two safety warnings from the FDA and reports of hundreds of deaths and serious injuries among patients and their caregivers.


Chantix Side Effects

The FDA recently stated that "Serious neuropsychiatric symptoms have occurred in patients taking Chantix." A more recent study indicates other side effects including heart trouble, seizures and diabetes.


Consumer Advocacy Award

The Massachusetts Academy of Trial Attorneys honors Mark Lanier based on his work for injured individuals across the United States. 


Vytorin and Zetia

A recent clinical study showed the cholesterol-lowering drugs Vytorin and Zetia may not work at all.


Trasylol Studies

Studies say Trasylol patients have increased risk of kidney damage, heart attacks and strokes.


Law Firm Recognized

Lanier recognized as one of the 500 'Leading Lawyers in America' and one of Texas' top attorneys.


Heparin Recall

There has been a recent, nationwide recall of Heparin Sodium USP.


Pharmaceutical Liability

Read about: Fosamax; ReNu with MoistureLoc contact lens solution; Zicam nasal gel; Ketek antibiotic; Composix Kugel Mesh Patch; and Avandia.

Law Firm Locations: Houston Law Firm | New York Law Firm | Los Angeles Law Firm | Palo Alto Law Firm
© 2008 The Lanier Law Firm. All rights reserved. Disclaimer: Client's rights and responsibilities.
Past results do not guarantee similar outcomes in future cases.
Contact The Lanier Law Firm for more information.
Attorney Advertising